Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1303

L2K-hIgG1

Home » Antibodies » L2K-hIgG1

Background of L2K-hIgG1

L2K is a humanized monoclonal antibody derived from OKT3, which reacts with an epitope on the epsilon-subunit within the human CD3 complex, and have potent immunosuppressive properties in vivo and has been proven effective in the treatment of renal, heart and liver allograft rejection. L2K sequence was widely used in many bispecific antibodies against both of the tumor associated antigen and CD3e.

Specifications

Catalog Number:
KB-1303
Antibody Name:
L2K-hIgG1
Isotype:
Human IgG1,kappa
FC Muations:
Target:
CD3
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA | FACS | Activation
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Pauline Wimberger Wei Xiang &Doris Mayr et al. Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody. IJC. Volume105, Issue2(2003).